Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy
02 January 2026

Shunt Benefit in iNPH, Downstream Revenue, Anticoagulant Monotherapy

Neurology Today in 5

About

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about the benefit of shunts in idiopathic normal-pressure hydrocephalus, how neurologists drive downstream revenue, and anticoagulant monotherapy after stroke.